HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Jeffrey M. Pearl Hillel Laks Davis C. Drinkwater, Jr Paul A. Chang Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pearl, J. M. Articles by Chang, P. A. Search for Related Content PubMed PubMed Citation Articles by Pearl, J. M. Articles by Chang, P. A.

Ann Thorac Surg 1994;57:1636-1641
© 1994 The Society of Thoracic Surgeons

---

Articles

Fumarate-enriched blood cardioplegia results in complete functional recovery of immature myocardium

Division of Cardiothoracic Surgery, Department of Surgery, University of California at Los Angeles Medical Center, Los Angeles, California, USA

Accepted for publication October 29, 1993.

^_* Address reprint requests to Dr Laks, Division of Cardiothoracic Surgery, UCLA Medical Center, CHS 62-182, 10833 LeConte Ave, Los Angeles, CA 90024.

Amino acid enrichment of cardioplegic solutions has been shown to improve both the metabolic and functional recovery of ischemic myocardium. However, because of the marked systemic vasodilatation involved, use of amino acid enrichment is limited to the periods of induction and reperfusion. Fumarate is a Krebs' cycle intermediate whose conversion to succinate is responsible for the generation of adenosone triphosphate and the oxidation of the reduced form of nicotinamide-adenine nucleotide which is the pathway by which aspartate exerts its effect. Fumarate may also function as a free-radical scavenger and is involved in calcium transport. To determine if fumarate-enriched blood cardioplegia would improve the functional recovery of the neonatal heart, 14 neonatal piglet hearts were isolated and placed on a blood-perfused working heart circuit. After the baseline functional and metabolic assessment was done, cold ischemic arrest was initiated with either standard blood cardioplegic solution (group I; N = 7) or fumarate-enriched (13 mmol/L) blood cardioplegic solution (group II; N = 7). Cardioplegic solution was given at a pressure of 40 mm Hg every 20 minutes for 2 hours, and topical hypothermia was used. Sixty minutes after warm whole blood reperfusion, the functional recovery at left atrial pressures of 3, 6, 9, and 12 mm Hg was 70%, 66%, 66%, and 65%, respectively, in group I, versus 102%, 106%, 105%, and 109%, respectively, in group II (p < 0.05). The tissue creatinine phosphate levels after reperfusion were significantly higher in group II hearts (15.0 ± 1.2 µmol/g dry heart tissue) than in group I hearts (9.2 ± 1.9 µmol/g dry heart tissue), although the adenosine triphosphate levels were not significantly different. The addition of fumarate to standard blood cardioplegic solution results in significantly improved (100%) functional recovery compared with that observed for standard blood cardioplegic solution.

This article has been cited by other articles:

				T. Doenst, C. Schlensak, and F. Beyersdorf Cardioplegia in pediatric cardiac surgery: do we believe in magic? Ann. Thorac. Surg., May 1, 2003; 75(5): 1668 - 1677. [Abstract] [Full Text] [PDF]

				C. D. Hardin, G. Lazzarino, B. Tavazzi, D. Di Pierro, T. M. Roberts, B. Giardina, and M. J. Rovetto Myocardial metabolism of exogenous FDP is consistent with transport by a dicarboxylate transporter Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2654 - H2660. [Abstract] [Full Text] [PDF]

				J. M. Weinberg, M. A. Venkatachalam, N. F. Roeser, P. Saikumar, Z. Dong, R. A. Senter, and I. Nissim Anaerobic and aerobic pathways for salvage of proximal tubules from hypoxia-induced mitochondrial injury Am J Physiol Renal Physiol, November 1, 2000; 279(5): F927 - F943. [Abstract] [Full Text] [PDF]

				M. T. Kronon, B. S. Allen, K. S. Bolling, S. Rahman, T. Wang, H. S. Maniar, S. M. Prasad, and M. N. Ilbawi The role of cardioplegia induction temperature and amino acid enrichment in neonatal myocardial protection Ann. Thorac. Surg., September 1, 2000; 70(3): 756 - 764. [Abstract] [Full Text] [PDF]

				J. Martin, K. Sarai, M. Yoshitake, J. Haberstroh, N. Takahashi, G. Lutter, and F. Beyersdorf Orthotopic transplantation of pig hearts harvested after 30 min of normothermic ischemia: controlled reperfusion with blood cardioplegia containing the Na+-H+-exchange inhibitor HOE 642 Eur J Cardiothorac Surg, December 1, 1998; 14(6): 607 - 614. [Abstract] [Full Text] [PDF]

				M. Chandra Reanimation and engraftment of the asystolic primate heart J. Thorac. Cardiovasc. Surg., March 1, 1996; 111(3): 684 - 684. [Full Text]

				E. R. Rosenkranz Substrate enhancement of cardioplegic solution: Experimental studies and clinical evaluation Ann. Thorac. Surg., September 1, 1995; 60(3): 797 - 800. [Abstract] [PDF]